GVHD prophylaxis

Graft-versus-host disease (GVHD) prophylaxis involves medications and strategies to prevent the donor's immune cells from attacking the recipient’s tissues after a stem cell transplant. These medications, such as immunosuppressants, reduce the immune response, decreasing the risk of GVHD. The goal is to balance preventing harmful immune reactions while allowing the transplanted cells to fight any remaining disease. Prophylaxis timing and choice depend on factors like donor type and patient health, aiming to improve transplant success and minimize complications.